m/z | Candidate molecule | Median ion intensity | P value (ālog10) | |
---|---|---|---|---|
Non-cancer | CRLM | |||
Dominant in non-cancer liver specimen | ||||
ā760.50 | PE (38:7ā16:1/22:6) | 12,970.0 | 0.0 | 28.3 |
ā712.50 | PE (34:3ā16:0/18:3) | 19,792.0 | 0.0 | 27.7 |
ā788.55 | PE (40:7ā18:1/22:6) | 153,466.0 | 0.0 | 26.8 |
ā806.50 | PS (40:7ā18:1/22:6) | 8562.0 | 0.0 | 27.0 |
ā863.55 | PI (36:1ā16:0/20:1) | 8974.0 | 0.0 | 25.6 |
ā762.50 | PE (38:6ā16:0/22:6) | 2,058,266.0 | 57,728.0 | 25.5 |
ā736.50 | PE (36:5ā16:0/20:5) | 121,756.0 | 11,973.0 | 25.4 |
ā850.55 | PC (38:6ā16:0/22:6) | 480,734.0 | 29,393.0 | 25.4 |
ā738.50 | PE (36:4ā16:0/20:4) | 566,367.0 | 63,337.0 | 25.4 |
ā790.55 | PE (40:6ā18:0/22:6) | 1,171,554.0 | 66,685.0 | 25.4 |
Dominant in CRLM specimen | ||||
ā747.55 | SM (34:1-d18:1/16:0) | 175,390.0 | 375,704.0 | 20.2 |
ā830.60 | PC (36:2ā16:0/20:2) | 0.0 | 9619.0 | 19.9 |
ā800.60 | PE (40:1ā18:1/22:0) | 0.0 | 17,383.0 | 18.6 |
ā856.60 | PC (38:3ā18:1/20:2) | 0.0 | 8239.0 | 18.2 |
ā768.55 | PE (38:3ā18:1/20:2) | 0.0 | 39,983.0 | 16.3 |
ā858.60 | PC (38:2ā18:1/20:1) | 0.0 | 18,930.0 | 16.3 |
ā766.55 | PE (38:4ā18:2/20:2) | 0.0 | 17,581.0 | 14.1 |
ā830.60 | PC (36:2ā16:1/20:1) | 0.0 | 8761.0 | 10.9 |
ā716.55 | PE (34:1ā16:1/18:0) | 0.0 | 65,533.0 | 10.9 |
ā786.55 | PS (36:2ā18:1/18:1) | 0.0 | 3703.0 | 8.4 |